A systematic literature review (SLR) was conducted to describe the resistance mutation profiles and impact of resistance mutations on clinical outcomes in adults with locally advanced or metastatic NSCLC (a/mNSCLC) with EGFR mutation. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.